A town in Mallorca is enforcing new motoring rules to reduce traffic in its busiest streets, which will impact UK ...
Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...